Search Results 141-150 of 17508 for colitis
... ulcerative colitis with up to 60 weeks of treatment. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...
Overview. Gastroenteritis is an inflammation of the stomach and intestines that can cause watery diarrhea, nausea and vomiting. Gastroenteritis is often called ...
A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis · More about research at Mayo ...
... colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis. Has received any of the following for the treatment of ...
A Study of the Long-Term Safety and Effectiveness of Adalimumab for Repeat Treatment of Pediatric Patients with Ulcerative Colitis · Overview · Participation ...
Kinnucan has expertise in the evaluation and management of patients with inflammatory bowel disease (IBD) including ulcerative colitis and Crohn's disease, as ...
The purpose of the trial is to determine the safety and efficacy of RPC1063 in patients diagnosed with moderate to severe ulcerative colitis. Participation ...
IBD encompasses a range of disorders involving inflammation of the digestive tract, including ulcerative colitis and Crohn's disease. Symptoms for both ...
Colitis, pseudomembranous. See. Pseudomembranous colitis. Colitis, ulcerative. See. Ulcerative colitis. Collapsed lung. See. Atelectasis. Collapsed lung. See.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.